Nisa Investment Advisors
STOK icon

Nisa Investment Advisors’s Stoke Therapeutics STOK Stock Holding History

Nisa Investment Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.9K Buy
2,961
+123
+4% +$3.95K ﹤0.01% 1567
2026
Q1 		$92.4K Buy
2,838
+402
+17% +$13.2K ﹤0.01% 1457
2025
Q4 		$77.3K Sell
2,436
-296
-11% -$8.9K ﹤0.01% 1511
2025
Q3 		$64.2K Hold
2,732
– – ﹤0.01% 1561
2025
Q2 		$31K Sell
2,732
-28
-1% -$266 ﹤0.01% 1739
2025
Q1 		$18.4K Buy
2,760
+56
+2% +$522 ﹤0.01% 1916
2024
Q4 		$29.8K Buy
2,704
+10
+0.4% +$123 ﹤0.01% 1812
2024
Q3 		$33.1K Sell
2,694
-295
-10% -$4.18K ﹤0.01% 1750
2024
Q2 		$40.4K Buy
2,989
+1,038
+53% +$14K ﹤0.01% 1726
2024
Q1 		$26.3K Buy
1,951
+17
+0.9% +$103 ﹤0.01% 1804
2023
Q4 		$10.2K Buy
1,934
+1,869
+2,875% +$7.99K ﹤0.01% 2041
2023
Q3 		$256 Buy
65
+17
+35% +$112 ﹤0.01% 2633
2023
Q2 		$510 Sell
48
-800
-94% -$8.51K ﹤0.01% 2555
2023
Q1 		$7K Buy
848
+800
+1,667% +$7.22K ﹤0.01% 2210
2022
Q4 		$0 Buy
+48
New +$499 ﹤0.01% 2714

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nisa Investment Advisors's STOK Position: Q2 2026 in Review

Nisa Investment Advisors increased its Stoke Therapeutics (STOK) stake by 4.3% in Q2 2026, buying an estimated $3.95K and bringing the position to 2,961 shares worth $96.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1567.

Nisa Investment Advisors first reported a position in STOK in Q4 2022 and has held it in 15 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Nisa Investment Advisors held 2,961 shares of Stoke Therapeutics worth $96.9K as of Q2 2026.
  • Nisa Investment Advisors bought 123 Stoke Therapeutics shares in Q2 2026, an estimated $3.95K.
  • Stoke Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1567 holding.
  • Nisa Investment Advisors first reported a position in Stoke Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.